BioMérieux

Works in Infectious disease · Neurology · Renal & urogenital · Respiratory · Women's health

BioMérieux is a clinical trial sponsor. It has 1 active clinical trial with 720 planned participants, across 5 therapeutic areas. Since 2021 it has completed 10 trials and stopped 2 early.

Trial track record · since 2021

1Active trials720 planned participants
10Completed0 with results posted
2Stopped early17% of finished trials

Pipeline · 1 active trial

StageTrialStatus

Questions about BioMérieux

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-30.

Approve Suite is not affiliated with BioMérieux.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.